Beovu and Visual acuity reduced transiently - a phase IV clinical study of FDA data

Summary:

Visual acuity reduced transiently is reported as a side effect among people who take Beovu (brolucizumab-dbll), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lucentis, and have Age-related macular degeneration.

The phase IV clinical study analyzes which people have Visual acuity reduced transiently when taking Beovu. It is created by eHealthMe based on reports of 3,872 people who have side effects when taking Beovu from the FDA, and is updated regularly.

What is Beovu?

Beovu has active ingredients of brolucizumab-dbll. eHealthMe is studying from 3,872 Beovu users. Check the latest studies of Beovu.

What is Visual acuity reduced transiently?

Visual acuity reduced transiently is found to be associated with 30 drugs and 108 conditions by eHealthMe. Check the latest studies of Visual acuity reduced transiently.

On Jul, 10, 2026

3,872 people reported to have side effects when taking Beovu.
Among them, 65 people (1.68%) have Visual acuity reduced transiently.

Could Beovu cause Visual acuity reduced transiently?

Among these 65 people:

How long have people been on Beovu when they have Visual acuity reduced transiently? *

What is the gender of people who have Visual acuity reduced transiently when taking Beovu? *

female: 32.31 %
male: 67.69 %

What is the age of people who have Visual acuity reduced transiently when taking Beovu? *

What are other drugs people take besides Beovu? *

Lucentis: 7 people, 10.77%
Eylea: 3 people, 4.62%
Triamcinolone Acetonide: 2 people, 3.08%
Moxifloxacin Hydrochloride: 2 people, 3.08%
Prolia: 1 person, 1.54%
Pradaxa: 1 person, 1.54%
Moxifloxacin: 1 person, 1.54%
Levofloxacin: 1 person, 1.54%
Dexamethasone: 1 person, 1.54%

What are other side effects people have besides Visual acuity reduced transiently? *

Vitreous Opacities (vitreous opacities generally develop as aging changes within the eye): 35 people, 53.85%
Vitreous Floaters (spots before the eyes): 35 people, 53.85%
Vision Blurred: 31 people, 47.69%
Retinal Vasculitis (a sight-threatening inflammatory eye condition that involves the retinal vessels): 28 people, 43.08%
Uveitis (inflammation of the uvea): 25 people, 38.46%
Eye Inflammation: 23 people, 35.38%
Anterior Chamber Inflammation: 22 people, 33.85%
Retinal Haemorrhage (bleeding from retina): 10 people, 15.38%
Age-Related Macular Degeneration: 9 people, 13.85%
Conjunctival Hyperaemia (congestion of conjunctival vessels): 9 people, 13.85%

What are the existing conditions these people have? *

Age-Related Macular Degeneration: 45 people, 69.23%
Polypoidal Choroidal Vasculopathy (polyp-like sub-retinal pigment epithelium vascular abnormalities predominantly found in the macula and peripapillary region): 15 people, 23.08%
Nearsightedness (difficulty in seeing the far objects): 2 people, 3.08%
Detachment Of Retinal Pigment Epithelium: 2 people, 3.08%
Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 2 people, 3.08%
Vitreous Opacities (vitreous opacities generally develop as aging changes within the eye): 1 person, 1.54%
High Blood Pressure: 1 person, 1.54%
Dyslipidaemia (abnormal amount of lipids): 1 person, 1.54%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 1 person, 1.54%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 1 person, 1.54%

* Approximation only. Some reports may have incomplete information.

Do you take Beovu and have Visual acuity reduced transiently?

- Check whether Visual acuity reduced transiently is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Beovu:

Beovu (3,872 reports)

Browse all side effects of Beovu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual acuity reduced transiently:

Visual acuity reduced transiently (30 drugs)

Browse all the conditions that are associated with Visual acuity reduced transiently:

Visual acuity reduced transiently (108 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on brolucizumab-dbll (the active ingredients of Beovu) and Beovu (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.